当前位置: 首页 > 期刊 > 《特别健康.下半月》 > 2017年第7期
编号:13079563
A REVIEW ON CANCER IMMUNOTHERAPY VIA DENDRITIC CELLS(6)
http://www.100md.com 2017年10月8日 《特别健康·下半月》 2017年第7期
     4.Clinicalusesofdendriticcellvaccines:

    Researchers have been trying to make cancer vaccines for the past many years and first it was thought to be harder. Now in recent years the new cancer DC vaccines have developed that are known as “Adjuvants”. These vaccine are divided into two types, preventive vaccine and therapeutic vaccines. Since the past decade the dendritic cells have been used in clinical trials as cellular mediators of therapeutic vaccination of patients with cancer. This approach is further facilitated through indentification of in vitro culture methods ......
上一页1 2 3 4 5 6 7下一页

您现在查看是摘要页,全文长 3001 字符